The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

ABSTRACT:

Purpose

To evaluate the effect of physician face mask use on rates and outcomes of postinjection endophthalmitis.

Design

Retrospective, comparative cohort study.

Methods

Setting: Single-center. StudyPopulation: Eyes receiving intravitreal anti-vascular endothelial growth factor injections from July 1, 2013, to September 1, 2019.

Intervention

Cases were divided into "Face Mask" group if face masks were worn by the physician during intravitreal injections or "No Talking" group if no face mask was worn but a no-talking policy was observed during intravitreal injections. MainOutcomeMeasures: Rate of endophthalmitis, visual acuity, and microbial spectrum.

Results

Of 483,622 intravitreal injections administered, 168 out of 453,460 (0.0371%) cases of endophthal

SUBMITTER: Patel SN 

PROVIDER: S-EPMC7462768 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature